|  | Number and 1-month survival rate (%) | χ 2 value | P value | |||
---|---|---|---|---|---|---|---|
 |  | Group 1 | Group 2 |  |  | ||
1 | ≤4(Group 1)/≥5(Group 2) | 0 | (0.00%) | 6480 | (31.08%) | 0.45 | 0.5019 |
2 | ≤5(Group 1)/≥6(Group 2) | 0 | (0.00%) | 6480 | (31.08%) | 0.90 | 0.3423 |
3 | ≤6(Group 1)/≥7(Group 2) | 1 | (25.00%) | 6479 | (31.08%) | 0.07 | 0.7928 |
4 | ≤7(Group 1)/≥8(Group 2) | 6 | (60.00%) | 6474 | (31.06%) | 3.91 | 0.0481 |
5 | ≤8(Group 1)/≥9(Group 2) | 10 | (66.67%) | 6470 | (31.05%) | 8.88 | 0.0029 |
6 | ≤9(Group 1)/≥10(Group 2) | 18 | (54.55%) | 6462 | (31.04%) | 8.50 | 0.0036 |
7 | ≤10(Group 1) ≥11(Group 2) | 26 | (56.52%) | 6454 | (31.02%) | 13.93 | 0.0002 |
8 | ≤11(Group 1)/≥12(Group 2) | 38 | (52.05%) | 6442 | (31.00%) | 15.05 | <0.0001 |
9 | ≤12(Group 1)/≥13(Group 2) | 58 | (47.54%) | 6422 | (30.98%) | 15.53 | <0.0001 |
10 | ≤13(Group 1)/≥14(Group 2) | 85 | (50.00%) | 6395 | (30.92%) | 28.65 | <0.0001 |
11 | ≤14(Group 1)/≥15(Group 2) | 142 | (50.71%) | 6338 | (30.81%) | 51.09 | <0.0001 |
12 | ≤15(Group 1) ≥16(Group 2) | 220 | (50.00%) | 6260 | (30.67%) | 75.14 | <0.0001 |
13 | ≤16(Group 1)/≥17(Group 2) | 336 | (50.15%) | 6144 | (30.44%) | 117.55 | <0.0001 |
14 | ≤17(Group 1)/≥18(Group 2) | 453 | (46.85%) | 6027 | (30.31%) | 117.71 | <0.0001 |
15 | ≤18(Group 1)/≥19(Group 2) | 614 | (45.92%) | 5866 | (30.06%) | 147.00 | <0.0001 |
16 | ≤19(Group 1)/≥20(Group 2) | 800 | (44.57%) | 5680 | (29.81%) | 166.88 | <0.0001 |
17 | ≤20(Group 1) ≥21(Group 2) | 966 | (43.83%) | 5514 | (29.57%) | 187.09 | <0.0001 |
18 | ≤21(Group 1)/≥22(Group 2) | 1234 | (43.54%) | 5246 | (29.12%) | 237.92 | <0.0001 |
19 | ≤22(Group 1)/≥23(Group 2) | 1469 | (42.25%) | 5011 | (28.84%) | 243.13 | <0.0001 |
20 | ≤23(Group 1)/≥24(Group 2) | 1693 | (40.23%) | 4787 | (28.76%) | 206.30 | <0.0001 |
21 | ≤24(Group 1)/≥25(Group 2) | 1985 | (39.80%) | 4495 | (28.34%) | 232.64 | <0.0001 |
22 | ≤25(Group 1) ≥26(Group 2) | 2269 | (39.15%) | 4211 | (27.97%) | 244.07 | <0.0001 |
23 | ≤26(Group 1)/≥27(Group 2) | 2601 | (38.87%) | 3879 | (27.39%) | 279.53 | <0.0001 |
24 | ≤27(Group 1)/≥28(Group 2) | 2863 | (37.78%) | 3617 | (27.25%) | 249.38 | <0.0001 |
25 | ≤28(Group 1)/≥29(Group 2) | 3164 | (37.11%) | 3316 | (26.91%) | 244.74 | <0.0001 |
26 | ≤29(Group 1)/≥30(Group 2) | 3446 | (36.69%) | 3034 | (26.47%) | 251.69 | <0.0001 |
27 | ≤30(Group 1) ≥31(Group 2) | 3683 | (36.14%) | 2797 | (26.24%) | 238.47 | <0.0001 |
28 | ≤31(Group 1)/≥32(Group 2) | 3929 | (35.52%) | 2551 | (26.06%) | 216.89 | <0.0001 |
29 | ≤32(Group 1)/≥33(Group 2) | 4178 | (35.16%) | 2302 | (25.67%) | 215.18 | <0.0001 |
30 | ≤33(Group 1)/≥34(Group 2) | 4380 | (34.63%) | 2100 | (25.60%) | 189.41 | <0.0001 |
31 | ≤34(Group 1)/≥35(Group 2) | 4545 | (34.33%) | 1935 | (25.42%) | 179.13 | <0.0001 |
32 | ≤35(Group 1) ≥36(Group 2) | 4714 | (33.91%) | 1766 | (25.41%) | 156.33 | <0.0001 |
33 | ≤36(Group 1)/≥37(Group 2) | 4865 | (33.56%) | 1615 | (25.41%) | 137.16 | <0.0001 |
34 | ≤37(Group 1)/≥38(Group 2) | 4998 | (33.23%) | 1482 | (25.51%) | 116.66 | <0.0001 |
35 | ≤38(Group 1)/≥39(Group 2) | 5145 | (32.94%) | 1335 | (25.53%) | 100.46 | <0.0001 |
36 | ≤39(Group 1)/≥40(Group 2) | 5262 | (32.64%) | 1218 | (25.75%) | 81.05 | <0.0001 |
37 | ≤40(Group 1) ≥41(Group 2) | 5356 | (32.37%) | 1124 | (26.12%) | 62.18 | <0.0001 |
38 | ≤41(Group 1)/≥42(Group 2) | 5437 | (32.16%) | 1043 | (26.43%) | 49.20 | <0.0001 |
39 | ≤42(Group 1)/≥43(Group 2) | 5507 | (31.91%) | 973 | (27.07%) | 32.51 | <0.0001 |
40 | ≤43(Group 1)/≥44(Group 2) | 5583 | (31.74%) | 897 | (27.52%) | 22.78 | <0.0001 |
41 | ≤44(Group 1)/≥45(Group 2) | 5637 | (31.60%) | 843 | (27.96%) | 15.99 | <0.0001 |
42 | ≤45(Group 1) ≥46(Group 2) | 5703 | (31.44%) | 777 | (28.67%) | 8.42 | 0.0037 |
43 | ≤46(Group 1)/≥47(Group 2) | 5766 | (31.38%) | 714 | (28.83%) | 6.66 | 0.0099 |
44 | ≤47(Group 1)/≥48(Group 2) | 5810 | (31.25%) | 670 | (29.63%) | 2.47 | 0.1159 |
45 | ≤48(Group 1)/≥49(Group 2) | 5856 | (31.22%) | 624 | (29.84%) | 1.66 | 0.1981 |
46 | ≤49(Group 1)/≥50(Group 2) | 5900 | (31.15%) | 580 | (30.32%) | 0.57 | 0.4518 |
47 | ≤50(Group 1)/≥51(Group 2) | 5949 | (31.15%) | 531 | (30.33%) | 0.50 | 0.4774 |